HALOZYME THERAPEUTICS, INC.: operating_income
| Value | {"amount": -80433637, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | superseded |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:23.728018+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/21a6dd40-e874-40c4-85d4-b8c1f82b2d25
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-14-000033Retrieved: 2026-08-19T11:36:23.728018+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/operating-income/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/21a6dd40-e874-40c4-85d4-b8c1f82b2d25
History
- no predecessors — first report